1-5 of 5
Mohamed L. Sorror, MD MS
Close
Sort by
Journal Articles

Pre-Transplant Expressions of Micrornas Are Associated with Both Comorbidity Burden and Mortality Risks in Patients (Pts) with Acute Leukemia (AL) in Complete Remission (CR) Given Allogeneic Hematopoietic Cell Transplantation (HCT)

Mohamed L. Sorror, MD MS, Theodore A Gooley, PhD, Kirsteen Maclean, PhD, Shamali Roy, PhD, Jesse Hubbard, Mario Marcondes, MD PhD, Beverly Torok-Storb, PhD, Tewari Muneesh, MD PhD
Journal: Blood
Blood (2015) 126 (23): 385.
https://doi.org/10.1182/blood.V126.23.385.385
Published: 2015
Journal Articles

A Regimen of Treosulfan and Fludarabine Followed by Allogeneic Hematopoietic Cell Transplantation (HCT) for High-Risk Hematologic Malignancies Is Associated with Low Treatment-Related Mortality

Eneida R. Nemecek, MD, Mohamed L. Sorror, MD, MS, Kristine C. Doney, MD, Bart Lee Scott, MD, Tibor J. Kovacsovics, MD, Richard Thomas Maziarz, MD, Ann E Woolfrey, MD, Jean Sanders, MD, Paul V. O’Donnell, Katherine Guthrie, PhD, H. Joachim Deeg, MD
Journal: Blood
Blood (2008) 112 (11): 2994.
https://doi.org/10.1182/blood.V112.11.2994.2994
Published: 2008
Journal Articles

Transfusion Requirements in Allogeneic Hematopoietic Cell Transplantation (HCT) Recipients Given Either Myeloablative or Nonmyeloablative Conditioning, and Effect of ABO Incompatibility on HCT Outcomes.

Zejing Wang, MD, PhD, Mohamed L. Sorror, MD, MS, Wendy Leisenring, Sc.D., Gary Schoch, David G. Malonely, MD, PhD, Brenda M. Sandmaier, MD, Rainer F. Storb, MD
Journal: Blood
Blood (2008) 112 (11): 3268.
https://doi.org/10.1182/blood.V112.11.3268.3268
Published: 2008
Journal Articles

Salvage Allogeneic Hematopoietic Cell Transplantation with Fludarabine and Total Body Irradiation (3 or 4 Gy) after Failure of First Allografts.

Boglarka Gyurkocza, MD, Thai M. Cao, MD, Rainer F. Storb, MD, Thoralf Lange, MD, Wendy Leisenring, Sc.D., Georg Franke, MD, Mohamed L. Sorror, MD, MS, David G. Maloney, MD, PhD, Judith Shizuru, MD, PhD, Brenda M. Sandmaier, MD
Journal: Blood
Blood (2008) 112 (11): 3272.
https://doi.org/10.1182/blood.V112.11.3272.3272
Published: 2008
Journal Articles

Sustained Graft-Versus-Lymphoma Effect among Patients (pts) with Mantle Cell Lymphoma (MCL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT).

Mohamed L. Sorror, MD, MS, Barry Storer, PhD, Brenda M. Sandmaier, MD, Michael Maris, MD, Thomas Chauncey, MD, Richard T. Maziarz, MD, Michael Pulsipher, MD, Judith Shizuru, MD, PhD, Dietger Niederwieser, MD, Edward Agura, MD, James C. Wade, MD, MPH, Amelia A Langston, MD, Rainer F. Storb, MD, David G. Maloney, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2147.
https://doi.org/10.1182/blood.V112.11.2147.2147
Published: 2008